Short answer
SILICON LABORATORIES INC. (SLAB) filed its fiscal 2026 10-K annual report with the SEC on Feb 10, 2026.
- Top risk flagged: Merger completion risk: $259M termination fee payable if Merger Agreement terminated under specified circumstances
SILICON LABORATORIES INC. FY2026 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business model: Analog-intensive, mixed-signal ICs for secure, intelligent wireless IoT connectivity across industrial, commercial, home, and healthcare sectors
- New emphasis on Series 3 wireless MCU portfolio launched in 2025 using 22 nm process for enhanced compute, interoperability, energy efficiency, and advanced security
- Strategic shift: Pending merger with Texas Instruments announced Feb 2026 at $231/share cash, expected closing H1 2027, positioning Silicon Labs as a TI subsidiary
- R&D spend increased to $353.2M in fiscal 2025 from $332.2M in 2024, supporting advances in IoT-focused modules, security, and mixed-signal integration
- 91% of revenues sourced outside the U.S., highlighting strong global market presence and extensive distributor network including Arrow Electronics (28%) and Edom Technology (21%)
Management Discussion & Analysis
- Inventory valuation methodology includes write-downs for aged/obsolete inventory over 24 months
- Revenue recognized when control transfers using a five-step process estimating variable consideration
- Income tax accounting involves valuation allowances and uncertain tax positions reassessed quarterly
Risk Factors
- Merger completion risk: $259M termination fee payable if Merger Agreement terminated under specified circumstances
- Geopolitical cyber threat: U.S. Cybersecurity Agency's 2022 “Shields Up” alert warns of Russian cyber-attacks affecting US organizations
- Supply chain concentration: most manufacturers, assemblers, test providers, distributors and customers concentrated in same geographic region
- Competitive risk: key competitors include Espressif, Infineon, MediaTek, Qualcomm, Texas Instruments facing rapid technological change and AI integration
- R&D concentration risk: fiscal 2025 R&D expense $353.2M, 45.0% of revenues focused on limited new technologies and products with market acceptance uncertainty
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.